Baljit (Boo) Samra
Chief Operating Officer
Baljit (Boo) Samra was appointed as the DCRI’s Chief Operating Officer (COO) in 2016, rejoining the DCRI after a 14-year gap. With more than 20 years of experience holding positions of increasing responsibility in clinical research, Samra is a seasoned leader with global exposure and expertise in IT, quality, operations and general management. His experience spans the globe, with international exposure in Europe, the United States, and Asia Pacific including China, Japan, and India.
Samra now leads DCRI executive operations and is a member of the DCRI executive leadership team, working to define and implement operational strategies across the organization. Together with DCRI's Interim Executive Director, Lesley H. Curtis PhD, Baljit advances DCRI's mission to develop and share knowledge that improves the care of patients around the world through innovative clinical research. His collaborative leadership style focuses on relationship building throughout the DCRI and with its partners globally.
Prior to rejoining the DCRI, Samra gained extensive experience with PAREXEL International as Corporate Vice President and Strategic Account Leader, where he was an integral part of the global executive team. Responsibilities included the growth and profitability of high-value, high-impact strategic partnerships spanning a portfolio across all therapeutic areas by developing, implementing, and achieving the business vision, strategy, plan, financial metrics and execution for the account.
Samra holds a bachelor of science degree in chemistry from the University of Manchester Institute of Science and Technology (UMIST) in the UK.
“In my role at the DCRI, I’m drawing on my relationship-based leadership style and learnings from my hands-on international exposure as an expatriate in Europe, India, China, Japan and the United States to work effectively within the organization and across all our partnerships … My vision is to continue to drive operational excellence at the DCRI, maximizing the efficiencies of process and technology to deliver benefits to patients.”